FDA Drug recall D-1059-2016
SECONAL SODIUM (secobarbital sodium) Capsules, USP, 100 mg, 100 Ct. Bottles, Rx Only
- FDA Drug
- Class III
- terminated
- Published 2016-07-06
On 2016-07-06 the FDA classified a Class III recall of SECONAL SODIUM (secobarbital sodium) Capsules, USP, 100 mg, 100 Ct. Bottles, Rx Only by Valeant Pharmaceuticals North America, citing labeling: Incorrect or Missing Package Insert: Package insert is missing warning regarding anaphylaxis.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1059-2016 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2016-06-10 |
| Published | 2016-07-06 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Valeant Pharmaceuticals North America |
| Distribution | US |
Product
SECONAL SODIUM (secobarbital sodium) Capsules, USP, 100 mg, 100 Ct. Bottles, Rx Only. Distributed by: Valeant Pharmaceuticals North America, LLC, Bridgewater, NJ 08807. NDC: 0187-4220-10.
Reason
Labeling: Incorrect or Missing Package Insert: Package insert is missing warning regarding anaphylaxis.
Identifiers
| code_info | Lot #: 2555979, Expiry: 09/2016. |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1059-2016%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.